|
Volumn 41, Issue 1, 2001, Pages 65-68
|
The current status of polycystic ovary syndrome
a,b a,c
a
MONASH IVF
(Australia)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENFLUOREX;
BIGUANIDE;
CLOMIFENE CITRATE;
ESTROGEN;
FENFLURAMINE;
FLUOXETINE;
GONADOTROPIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
LUTEINIZING HORMONE;
METFORMIN;
SEX HORMONE BINDING GLOBULIN;
THIAZOLIDINE DERIVATIVE;
TRIACYLGLYCEROL;
TROGLITAZONE;
ANOVULATION;
ARTICLE;
BEHAVIOR MODIFICATION;
CARDIOVASCULAR RISK;
CONTROLLED STUDY;
DIET THERAPY;
DYSLIPIDEMIA;
EXERCISE;
FEMALE;
HEREDITY;
HUMAN;
HYPERANDROGENISM;
HYPERTENSION;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LAPAROSCOPIC SURGERY;
LIPID BLOOD LEVEL;
MENSTRUAL IRREGULARITY;
METABOLIC DISORDER;
OBESITY;
OVARY POLYCYSTIC DISEASE;
OVULATION INDUCTION;
PRIORITY JOURNAL;
SCREENING;
SYMPTOMATOLOGY;
SYSTEMIC DISEASE;
CARDIOVASCULAR DISEASES;
EXERCISE;
FEMALE;
FERTILIZATION IN VITRO;
FORECASTING;
HUMANS;
HYPERINSULINISM;
INSULIN RESISTANCE;
LIFE STYLE;
MASS SCREENING;
OVULATION INDUCTION;
POLYCYSTIC OVARY SYNDROME;
PROGNOSIS;
RISK FACTORS;
|
EID: 0035098125
PISSN: 00048666
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1479-828X.2001.tb01296.x Document Type: Article |
Times cited : (28)
|
References (35)
|